Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D

About this grant

Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions across any stage of the developmental pathway, from prototype development, through pre-clinical refinement, to early-phase clinical studies (up to phase 2a) for CBRN threats. Applications must demonstrate how the proposed research will result in improved domestic preparedness for CBRN threats. There is a funding limit of £4 million per application and requested costs should be appropriate to the project. MRC will fund 80% of the full economic cost (FEC). You must submit a mandatory expression of interest (EOI) and be invited to submit a full application.